LATOXAP

Država: Izrael

Jezik: engleski

Izvor: Ministry of Health

Aktivni sastojci:

LATANOPROST; TIMOLOL AS MALEATE

Dostupno od:

PERRIGO ISRAEL AGENCIES LTD

ATC koda:

S01ED01

Farmaceutski oblik:

EYE DROPS

Sastav:

TIMOLOL AS MALEATE 5 MG / 1 ML; LATANOPROST 0.05 MG / 1 ML

Administracija rute:

OCULAR

Tip recepta:

Required

Proizveden od:

AEROPHARM GMBH, GERMANY

Područje terapije:

TIMOLOL

Terapijske indikacije:

Reduction of intraocular pressure in patients with open angle glaucoma and ocular hypertension who are insufficiently responsive to topical beta-blockers.

Datum autorizacije:

2015-09-20

Uputa o lijeku

PATIENT PACKAGE INSERT IN
ACCORDANCE WITH THE PHARMACISTS’
REGULATIONS (PREPARATIONS) - 1986
This medicine is dispensed with
a doctor’s prescription only
LATOXAP
EYE DROPS
Latanoprost 0.05 mg/ml
Timolol (as Maleate) 5 mg/ml
For the list of inactive and allergenic ingredients in the
preparation, please see section 6.
READ THIS LEAFLET CAREFULLY IN ITS ENTIRETY BEFORE USING
THE MEDICINE. This leaflet contains concise information
about the medicine. If you have further questions, refer
to the doctor or pharmacist.
This medicine has been prescribed to treat you. Do not
pass it on to others. It may harm them even if it seems
to you that their medical condition is similar to yours.
THIS MEDICINE IS INTENDED FOR TREATMENT OF ADULTS OVER
18 YEARS OF AGE.
The preparation contains benzalkonium chloride (a
preservative) that may cause irritation in the eyes and
may be absorbed by contact lenses and lead to their
discoloration. Avoid contact between the medicine
and soft contact lenses. See section 3: "How should
you use the medicine?".
1.
WHAT IS THE MEDICINE INTENDED FOR?
To reduce intraocular pressure in patients suffering from
open-angle glaucoma and from increased intraocular
pressure that are not fully responsive to beta blockers.
THERAPEUTIC GROUP:
Latanoprost - prostaglandin F2 analogue
Timolol – beta blocker
2.
BEFORE USING THE MEDICINE
DO NOT USE THIS MEDICINE IF:
∙ you are sensitive (allergic) to the active ingredients
or to any of the other ingredients contained in this
medicine (see section 6).
∙ you are sensitive (allergic) to preparations from the
beta blockers group
∙ you are suffering, or have suffered in the past,
from disturbances in the respiratory system, such
as: asthma, severe chronic obstructive bronchitis
(a severe lung disease that can be manifested
by breathing difficulty, heavy breathing and/or
prolonged cough)
∙ you are suffering from severely impaired heart
function or from severe heart rate disturbances
∙ you are pregnant, plan to become pregnant or are
breastfeeding
DO NOT USE